Most not long ago, it's been discovered that conolidine and the above mentioned derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in identical spots as classical opioid receptors, it binds to a wide array of endogenous opioids. Compared with most opioid receptors, this receptor functions being a scavenger and won't activate a 2… Read More